​

CeriBell Stock (NASDAQ:CBLL)

ForecastRevenueOwnershipFinancialsChartTranscripts
CeriBell by TradingView

Previous Close

$24.31

52W Range

$10.85 - $25.33

50D Avg

$20.85

200D Avg

$19.87

Market Cap

$926.18M

Avg Vol (3M)

$387.41K

Beta

0.81

Div Yield

-

CBLL Company Profile

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

327

IPO Date

Oct 11, 2024

Website

CBLL Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24
Subscription$21.73M$15.37M
Product$67.33M$50.08M

Fiscal year ends in Dec 25 | Currency in USD

CBLL Financial Summary

Dec 25Dec 24Dec 23
Revenue$89.06M$65.44M$45.23M
Operating Income$-58.40M$-39.71M$-30.04M
Net Income$-53.41M$-40.45M$-29.46M
EBITDA$-58.40M$-37.32M$-26.51M
Basic EPS$-1.46$-3.39$-1.26
Diluted EPS$-1.46$-3.39$-1.26

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q2 26Aug 10, 26 | 4:30 PM
Q1 26May 11, 26 | 4:30 PM
Q4 25Feb 24, 26 | 4:30 PM

Peer Comparison

TickerCompany
KIDSOrthoPediatrics Corp.
TMCITreace Medical Concepts, Inc.
QSIQuantum-Si incorporated
AUTLAutolus Therapeutics plc
LABStandard BioTools Inc.
BFLYButterfly Network, Inc.
SMLRSemler Scientific, Inc.
SRDXSurmodics, Inc.
VREXVarex Imaging Corporation